UNIVERSITY OF ALABAMA AT BIRMINGHAM
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- -
- Established
- 1969-01-01
- Employees
- 2K
- Market Cap
- -
- Website
- http://www.uab.edu
Imaging With [89Zr]Panitumumab-PET/MRI in Patients With Newly Diagnosed Colorectal Cancer
Phase 1
Withdrawn
- Conditions
- Metastatic Colon Cancer
- Interventions
- Drug: [89Zr]Panitumumab PET-MRI
- First Posted Date
- 2018-12-04
- Last Posted Date
- 2022-10-07
- Lead Sponsor
- University of Alabama at Birmingham
- Registration Number
- NCT03764137
- Locations
- 🇺🇸
UAB Advanced Imaging Facility, Birmingham, Alabama, United States
Conversion to Envarsus Post Kidney Transplant Protects Against BK Infection
Phase 2
Completed
- Conditions
- Renal Transplant Infection
- Interventions
- Drug: Study GroupDrug: Control Group
- First Posted Date
- 2018-12-03
- Last Posted Date
- 2023-07-27
- Lead Sponsor
- University of Alabama at Birmingham
- Target Recruit Count
- 89
- Registration Number
- NCT03762473
- Locations
- 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States
Assessment of Neuroinflammation in Central Inflammatory Disorders Using [F-18]DPA-714.
Phase 1
Recruiting
- Conditions
- FibromyalgiaChronic Fatigue SyndromeMultiple SclerosisHealthy
- Interventions
- Drug: DPA-714 PET/MRI
- First Posted Date
- 2018-11-30
- Last Posted Date
- 2024-12-18
- Lead Sponsor
- University of Alabama at Birmingham
- Target Recruit Count
- 120
- Registration Number
- NCT03759522
- Locations
- 🇺🇸
University of Alabama at Birmingham Medical Center, Birmingham, Alabama, United States
Regional Anesthesia to Reduce Opioid Use Following Functional Endoscopic Sinus Surgery
- First Posted Date
- 2018-11-29
- Last Posted Date
- 2022-08-31
- Lead Sponsor
- University of Alabama at Birmingham
- Target Recruit Count
- 46
- Registration Number
- NCT03757715
- Locations
- 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States
Effect of Whole Fruit on Glycemic Control in Adults With Type 2 Diabetes
Not Applicable
Completed
- Conditions
- Diabetes Mellitus, Type 2
- Interventions
- Behavioral: High-Fruit Diet
- First Posted Date
- 2018-11-29
- Last Posted Date
- 2024-03-05
- Lead Sponsor
- University of Alabama at Birmingham
- Target Recruit Count
- 33
- Registration Number
- NCT03758742
- Locations
- 🇺🇸
Department of Nutrition Sciences, University of Alabamam at Birmingham, Birmingham, Alabama, United States
Oxalobacter Formigenes Colonization and Urinary Oxalate Excretion
Not Applicable
Active, not recruiting
- Conditions
- Calcium Oxalate Urolithiasis
- Interventions
- Other: Oxalobacter formigenesOther: Low Oxalate DietOther: Moderately high oxalate/low calcium diet
- First Posted Date
- 2018-11-26
- Last Posted Date
- 2024-12-13
- Lead Sponsor
- University of Alabama at Birmingham
- Target Recruit Count
- 23
- Registration Number
- NCT03752684
- Locations
- 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States
Liposomal Bupivacaine in Rotator Cuff Repair
- First Posted Date
- 2018-11-13
- Last Posted Date
- 2024-05-16
- Lead Sponsor
- University of Alabama at Birmingham
- Target Recruit Count
- 64
- Registration Number
- NCT03738696
- Locations
- 🇺🇸
UAB Hospital-Highlands, Birmingham, Alabama, United States
Implementing the Decision-Aid for Lupus (IDEAL Strategy)
Active, not recruiting
- Conditions
- Systemic Lupus Erythematosus
- Interventions
- Other: SMILE Computerized Decision-Aid
- First Posted Date
- 2018-11-08
- Last Posted Date
- 2024-11-25
- Lead Sponsor
- University of Alabama at Birmingham
- Target Recruit Count
- 2000
- Registration Number
- NCT03735238
- Locations
- 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States
Virtual Reality Walking for Neuropathic Pain in Spinal Cord Injury
Not Applicable
Completed
- Conditions
- Spinal Cord InjuriesNeuropathic Pain
- Interventions
- Other: Non-Interactive Virtual Reality WalkingOther: Interactive Virtual Reality Walking
- First Posted Date
- 2018-11-08
- Last Posted Date
- 2021-11-16
- Lead Sponsor
- University of Alabama at Birmingham
- Target Recruit Count
- 27
- Registration Number
- NCT03735017
- Locations
- 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States
Genetic Evaluation for Medication Selection (GEMS) Study
Completed
- Conditions
- DementiaPsychiatric Disorders MoodBehavior Disorders
- First Posted Date
- 2018-11-08
- Last Posted Date
- 2019-10-07
- Lead Sponsor
- University of Alabama at Birmingham
- Target Recruit Count
- 40
- Registration Number
- NCT03736057
- Locations
- 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States
© Copyright 2025. All Rights Reserved by MedPath